Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase

Five‐fluorouracil (5‐FU) is a chemotherapeutic agent that is mainly metabolized by the rate‐limiting enzyme dihydropyrimidine dehydrogenase (DPD). The DPD enzyme activity deficiency involves a wide range of severities. Previous studies have demonstrated the effect of a DPYD single nucleotide polymor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jihyun, Kim, Andrew HyoungJin, Jeon, Inseung, Oh, Jaeseong, Jang, In‐Jin, Lee, SeungHwan, Cho, Joo‐Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099117/
https://www.ncbi.nlm.nih.gov/pubmed/34863048
http://dx.doi.org/10.1111/cts.13203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099117/
https://www.ncbi.nlm.nih.gov/pubmed/34863048
http://dx.doi.org/10.1111/cts.13203

Ejemplares similares